Lilly's Obesity Pill Faces Intensifying Competition from Novo

Eli Lilly's obesity pill recorded a modest performance in its second week on the market, as competition with pharmaceutical rival Novo Nordisk intensifies.

24 Apr, 17:52 — 24 Apr, 17:52

Post Share

Sources

Showing 1 of 1 sources

ReutersVery High4d ago

Lilly's obesity pill records modest second week as battle with Novo intensifies - Reuters

Lilly's obesity pill records modest second week as battle with Novo intensifies Reuters

Read full article →

PERSPECTA

PERSPECTA

Lilly's Obesity Pill Faces Intensifying Competition from Novo

Sources

Lilly's obesity pill records modest second week as battle with Novo intensifies - Reuters

Related Stories

Health experts call for workplace measures to curb burnout

Dangerous heat index hits 11 areas, peaks at 45ºC in Pili, Camarines Sur

Narrative verdict in death of woman who arrived to St James’s Hospital ‘in a crisis’

GITEX Future Health Africa 2026: AI in Healthcare Moves Toward Real-World Use

PERSPECTA